Phase II Study of DMT-Assisted Therapy for Treatment-Resistant Depression
Randomized, double-blind, placebo-controlled trial evaluating safety and efficacy of N,N-DMT with psychological support in patients with major depressive disorder.
- Status
- recruiting
- Institution
- Johns Hopkins University
- Principal investigator
- Dr. Roland Griffiths
- Start date
- 2025-03-01
- End date
- 2027-12-31
- Registry ID
- NCT05123456
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.